Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey Y Ku

Showing results (11-20 of 104) with videos related to

Pageof 11
Sort By:
Thoracic Surgery Clinics|November 9, 2013
Adjuvant (postoperative) therapy for esophageal cancerGeoffrey Y Ku, David H Ilson
Cancer Treatment Reviews|February 4, 2010
Esophagogastric cancer: targeted agentsGeoffrey Y Ku, David H Ilson
Expert Review of Anticancer Therapy|December 3, 2008
Multimodality therapy for the curative treatment of cancer of the esophagus and gastroesophageal junctionGeoffrey Y Ku, David H Ilson
Chinese Clinical Oncology|November 14, 2017
Preface on Esophagus CancerGeoffrey Y Ku, David H Ilson
Current Opinion in Gastroenterology|September 9, 2014
Management of gastric cancerGeoffrey Y Ku, David H Ilson
Current Treatment Options in Oncology|May 7, 2022
Approach to Resectable Gastric Cancer: Evolving Paradigm of Neoadjuvant and Adjuvant TreatmentMelissa A Lumish, Geoffrey Y Ku
Surgical Oncology Clinics of North America|June 9, 2009
Role of neoadjuvant therapy for esophageal adenocarcinomaGeoffrey Y Ku, David H Ilson
Seminars in Radiation Oncology|December 5, 2012
Chemotherapeutic options for gastroesophageal junction tumorsGeoffrey Y Ku, David H Ilson
Expert Opinion on Emerging Drugs|June 4, 2013
Emerging tyrosine kinase inhibitors for esophageal cancerGeoffrey Y Ku, David H Ilson
Clinical Advances in Hematology & Oncology : H&O|June 3, 2008
Preoperative therapy in esophageal cancerGeoffrey Y Ku, David H Ilson
Pageof 11

Showing results (11-20 of 104) with videos related to

Sort By:
Pageof 11
Thoracic Surgery Clinics|November 9, 2013
Adjuvant (postoperative) therapy for esophageal cancerGeoffrey Y Ku, David H Ilson
Cancer Treatment Reviews|February 4, 2010
Esophagogastric cancer: targeted agentsGeoffrey Y Ku, David H Ilson
Expert Review of Anticancer Therapy|December 3, 2008
Multimodality therapy for the curative treatment of cancer of the esophagus and gastroesophageal junctionGeoffrey Y Ku, David H Ilson
Chinese Clinical Oncology|November 14, 2017
Preface on Esophagus CancerGeoffrey Y Ku, David H Ilson
Current Opinion in Gastroenterology|September 9, 2014
Management of gastric cancerGeoffrey Y Ku, David H Ilson
Current Treatment Options in Oncology|May 7, 2022
Approach to Resectable Gastric Cancer: Evolving Paradigm of Neoadjuvant and Adjuvant TreatmentMelissa A Lumish, Geoffrey Y Ku
Surgical Oncology Clinics of North America|June 9, 2009
Role of neoadjuvant therapy for esophageal adenocarcinomaGeoffrey Y Ku, David H Ilson
Seminars in Radiation Oncology|December 5, 2012
Chemotherapeutic options for gastroesophageal junction tumorsGeoffrey Y Ku, David H Ilson
Expert Opinion on Emerging Drugs|June 4, 2013
Emerging tyrosine kinase inhibitors for esophageal cancerGeoffrey Y Ku, David H Ilson
Clinical Advances in Hematology & Oncology : H&O|June 3, 2008
Preoperative therapy in esophageal cancerGeoffrey Y Ku, David H Ilson
Pageof 11